Combination of anti-PD-1 inhibitors with radiotherapy for recurrent/metastatic squamous cell carcinoma in the head and neck region

被引：0
|
作者：
Tamaskovics, Balint [1 ]
Haussmann, Jan [1 ]
Neuwahl, Judith [1 ]
Jazmati, Danny [1 ]
Plettenberg, Christian [2 ]
Althaus, Laurenz [2 ]
Boelke, Edwin [1 ]
Matuschek, Christiane [1 ]
Budach, Wilfried [1 ]
机构：
[1] Univ Klinikum Dusseldorf, Klin Strahlentherapie & Radioonkol, Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Klin Hals Nasen Ohrenheilkunde, Dusseldorf, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P22-12
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [41] Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Kornek, V
    Scheithauer, W
    Glaser, C
    Toth, J
    Duman, M
    Formanek, M
    Hejna, M
    Kornfehl, J
    ONCOLOGY, 1999, 56 (01) : 24 - 27
  • [42] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [43] Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck
    Recchia, Francesco
    Candeloro, Giampiero
    Di Staso, Mario
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Tombolini, Vincenzo
    Rea, Silvio
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (04) : 413 - 419
  • [44] Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma
    Ducoulombier, Agnes
    Guigay, Joel
    Etienne-Grimaldi, Marie-Christine
    Saada-Bouzid, Esma
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 166 - 177
  • [45] Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma
    Specenier, Pol
    Vermorken, Jan B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (09) : 901 - 915
  • [46] Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
    Hedberg, Matthew L.
    Goh, Gerald
    Chiosea, Simion I.
    Bauman, Julie E.
    Freilino, Maria L.
    Zeng, Yan
    Wang, Lin
    Diergaarde, Brenda B.
    Gooding, William E.
    Lui, Vivian W. Y.
    Herbst, Roy S.
    Lifton, Richard P.
    Grandis, Jennifer R.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01): : 169 - 180
  • [47] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [48] Phase 1 and Pharmacokinetic Study of Everolimus in Combination With Cetuximab and Carboplatin for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Saba, Nabil F.
    Hurwitz, Selwyn J.
    Magliocca, Kelly
    Kim, Sungjin
    Owonikoko, Taofeek K.
    Harvey, Donald
    Ramalingam, Suresh S.
    Chen, Zhengjia
    Rogerio, Jackie
    Mendel, Jennifer
    Kono, Scott A.
    Lewis, Colleen
    Chen, Amy Y.
    Higgins, Kristin
    El-Deiry, Mark
    Wadsworth, Trad
    Beitler, Jonathan J.
    Shin, Dong M.
    Sun, Shi-Yong
    Khuri, Fadlo R.
    CANCER, 2014, 120 (24) : 3940 - 3951
  • [49] DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
    Starzer, Angelika Martina
    Heller, Gerwin
    Tomasich, Erwin
    Melchardt, Thomas
    Feldmann, Katharina
    Hatziioannou, Teresa
    Traint, Stefan
    Minichsdorfer, Christoph
    Schwarz-Nemec, Ursula
    Nackenhorst, Maja
    Muellauer, Leonhard
    Preusser, Matthias
    Berghoff, Anna Sophie
    Fuereder, Thorsten
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [50] Capecitabine (C) in combination with cisplatin (P) for recurrent and/or metastatic squamous cell carcinoma of head and neck (HN)
    Lopez-Argumedo, Gonzalo
    Perez-Hoyos, Teresa
    Rubio, Itziar
    Munoz, Alberto
    Mane, Joan M.
    Viteri, Ainhoa
    Pardo, Marta
    Barcelo, Ramon
    Martinez, Alejandro
    Lopez-Vivanco, Guillermo
    ANNALS OF ONCOLOGY, 2004, 15 : 140 - 140
12345